C12P 41/009
By reactions involving hydantoins or carbamoylamino compounds
Official title: {by reactions involving hydantoins or carbamoylamino compounds}
C12P41/009 (By reactions involving hydantoins or carbamoylamino compounds) appears on 43 US grants and 33 published applications in this corpus.
Search patents in C12P- Granted patents
- 43
- Published applications
- 33
- Assignees
- 24
- Inventors
- 116
- Latest grant
- 3 Nov 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 5 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 5 |
| 2003 | 3 | 7 |
| 2004 | 6 | 1 |
| 2005 | 0 | 2 |
| 2006 | 5 | 9 |
| 2007 | 1 | 0 |
| 2008 | 3 | 1 |
| 2009 | 1 | 1 |
| 2010 | 1 | 2 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 2 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Mutants of hydantoinase3 Nov 2020US 10,822,627 B2Evonik Operations GmbH
- Mutants of hydantoinase1 May 2018US 9,957,536 B2Evonik Technochemie GmbH
- Mutants for the preparation of D-amino acids24 Nov 2015US 9,194,009 B2Evonik Degussa GmbH
- Process for producing optically active α-methylcysteine derivative31 Mar 2015US 8,993,800 B2Kaneka Corporation
- DNA encoding hydantoinase, DNA encoding N-carbamyl-L-amino acid hydrolase, recombinant DNA, transformed cell, method of producing protein, and method of producing optically active amino acid11 Jun 2013US 8,460,902 B1Ajinomoto Co., Inc.
- Biocatalysts and methods for the synthesis of pregabalin intermediates6 Feb 2025US 2025/0043323 A1Enzymaster (Ningbo) Bio-Engineering Co., Ltd
- Enzymatic decarbamoylation of glufosinate derivatives30 Jan 2025US 2025/0034605 A1BASF SE
- Mutants of hydantoinase23 Aug 2018US 2018/0237814 A1Evonik Technochemie GmbH
- Mutants of hydantoinase26 Feb 2015US 2015/0056667 A1Evonik Industries AG
- Process for producing optically active alpha-methylcysteine derivative3 Oct 2013US 2013/0261331 A1Kaneka Corporation
Most cited
By later US patents
- Protein capable of catalyzing transamination stereoselectively, gene encoding said protein and use thereof26US 6,727,083 B2Sumitomo Chemical Company, Limited · 2004
- Protein capable of catalyzing transamination stereoselectively, gene encoding said protein and use thereof20US 6,413,752 B1Sumitomo Chemical Company, Limited · 2002
- Hydantoinase variants with improved properties and their use for the production of amino acids19US 6,524,837 B1California Institute of Technology · 2003
- Preparation of immobilized hydantoinase stabilized with divalent metal ions17US 5,283,182 ABeecham Group Limited · 1994
- Process for the preparation of L-car-bamyl-amino acids and of the corresponding L-amino acids14US 3,964,970 ASnam Progetti S.p.A. · 1976